ID

12993

Beschrijving

A Pilot Trial of AC (Adriamycin, Cyclophosphamide) Chemotherapy With G-CSF (Granulocyte Colony-Stimulating Factor) Followed by Infusional Taxol (Paclitaxel) as Adjuvant Treatment for High Risk Stage II and Stage III Breast Cancer Patients; ODM derived from: https://clinicaltrials.gov/show/NCT00001384

Link

https://clinicaltrials.gov/show/NCT00001384

Trefwoorden

Versies (1)
  1. 10-01-16 10-01-16 -
Geüploaded op

10 januari 2016

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Breast Cancer NCT00001384

Engels

Eligibility Breast Cancer NCT00001384

1 Formulieren  
Criteria
Beschrijving

Criteria

patients will be eligible for study either before or after receiving adjuvant radiation therapy.
Beschrijving

adjuvant radiation therapy

Datatype

boolean

Alias
UMLS CUI [1,1]
C1522449
UMLS CUI [1,2]
C1522673
patients with stage iii disease will be eligible to receive this regimen as neo-adjuvant chemotherapy or as adjuvant therapy if surgery was performed prior to patient referral.
Beschrijving

chemotherapy, surgery

Datatype

boolean

Alias
UMLS CUI [1]
C0392920
UMLS CUI [2]
C0038894
patients must be previously untreated with chemotherapy.
Beschrijving

chemotherapy

Datatype

boolean

Alias
UMLS CUI [1]
C0392920
there must be no history of previous malignancy except for cured non-melanoma skin cancer (basal or squamous cell carcinoma), cervical cancer in situ, or a past malignancy that has been inactive for over 5 years. patients with a prior history of lower stage contralateral breast cancer, treated with surgery, and/or radiation, but not chemotherapy, are eligible for this study.
Beschrijving

malignancies

Datatype

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2]
C0007117
UMLS CUI [3]
C0553723
UMLS CUI [4]
C0007847
UMLS CUI [5,1]
C0006142
UMLS CUI [5,2]
C0441988
performance status (karnofsky scale) must be greater than 70; ecog 0 to 2.
Beschrijving

karnofsky, ecog

Datatype

boolean

Alias
UMLS CUI [1]
C0206065
UMLS CUI [2]
C1520224
absolute granulocyte count greater than 1500 per microliter and platelet count greater than 100,000 per mm(3).
Beschrijving

granulocyte count, platelet count

Datatype

boolean

Alias
UMLS CUI [1]
C0857490
UMLS CUI [2]
C0005821
liver function tests (sgot, and total bilirubin) should be less than 2x upper limits of normal. serum creatinine should be less than 1.7 or creatinine clearance should be greater than 45 ml per min.
Beschrijving

liver function, renal function

Datatype

boolean

Alias
UMLS CUI [1]
C0201899
UMLS CUI [2]
C1278039
UMLS CUI [3]
C0201976
UMLS CUI [4]
C0373595
the patient must be able to give an informed consent, and to return to nci for treatment and adequate follow-up for the period the protocol requires.
Beschrijving

informed consent, follow up

Datatype

boolean

Alias
UMLS CUI [1]
C0021430
UMLS CUI [2]
C1522577
patients must be greater than or equal to 18 years of age.
Beschrijving

Age

Datatype

boolean

Alias
UMLS CUI [1]
C0001779
patients and/or their partners must be willing to practice a non-hormonal method of contraception during therapy and for 6 months following therapy.
Beschrijving

contraception

Datatype

boolean

Alias
UMLS CUI [1]
C0700589
patients who are poor medical or psychiatric risks because of nonmalignant systemic disease which would preclude them from being subjected to any treatments in this protocol are excluded.
Beschrijving

comorbidities, compliance

Datatype

boolean

Alias
UMLS CUI [1,1]
C1321605
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C0009488
patients must have a normal ejection fraction by muga scan and have no angina. patients should not currently require therapy for cardiac arrhythmias, congestive heart failure, or coronary artery disease.
Beschrijving

heart function, heart diseases

Datatype

boolean

Alias
UMLS CUI [1]
C0018799
UMLS CUI [2]
C0232164
no patients with a history of symptomatic cns disease.
Beschrijving

CNS disease

Datatype

boolean

Alias
UMLS CUI [1]
C0007682
no patients with allergy to any study medication.
Beschrijving

Allergy to protocol agent

Datatype

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C1521826
no pregnant or lactating women.
Beschrijving

pregnant or lactating

Datatype

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C2828358
patients with bleeding disorders are ineligible for study entry as are patients requiring chronic anticoagulation.
Beschrijving

bleeding disorders, anticoagulation

Datatype

boolean

Alias
UMLS CUI [1]
C0005779
UMLS CUI [2]
C0003280
Terug naar het begin van de pagina

Similar models

Eligibility Breast Cancer NCT00001384

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
adjuvant radiation therapy
Item
patients will be eligible for study either before or after receiving adjuvant radiation therapy.
boolean
C1522449 (UMLS CUI [1,1])
C1522673 (UMLS CUI [1,2])
chemotherapy, surgery
Item
patients with stage iii disease will be eligible to receive this regimen as neo-adjuvant chemotherapy or as adjuvant therapy if surgery was performed prior to patient referral.
boolean
C0392920 (UMLS CUI [1])
C0038894 (UMLS CUI [2])
chemotherapy
Item
patients must be previously untreated with chemotherapy.
boolean
C0392920 (UMLS CUI [1])
malignancies
Item
there must be no history of previous malignancy except for cured non-melanoma skin cancer (basal or squamous cell carcinoma), cervical cancer in situ, or a past malignancy that has been inactive for over 5 years. patients with a prior history of lower stage contralateral breast cancer, treated with surgery, and/or radiation, but not chemotherapy, are eligible for this study.
boolean
C0006826 (UMLS CUI [1])
C0007117 (UMLS CUI [2])
C0553723 (UMLS CUI [3])
C0007847 (UMLS CUI [4])
C0006142 (UMLS CUI [5,1])
C0441988 (UMLS CUI [5,2])
karnofsky, ecog
Item
performance status (karnofsky scale) must be greater than 70; ecog 0 to 2.
boolean
C0206065 (UMLS CUI [1])
C1520224 (UMLS CUI [2])
granulocyte count, platelet count
Item
absolute granulocyte count greater than 1500 per microliter and platelet count greater than 100,000 per mm(3).
boolean
C0857490 (UMLS CUI [1])
C0005821 (UMLS CUI [2])
liver function, renal function
Item
liver function tests (sgot, and total bilirubin) should be less than 2x upper limits of normal. serum creatinine should be less than 1.7 or creatinine clearance should be greater than 45 ml per min.
boolean
C0201899 (UMLS CUI [1])
C1278039 (UMLS CUI [2])
C0201976 (UMLS CUI [3])
C0373595 (UMLS CUI [4])
informed consent, follow up
Item
the patient must be able to give an informed consent, and to return to nci for treatment and adequate follow-up for the period the protocol requires.
boolean
C0021430 (UMLS CUI [1])
C1522577 (UMLS CUI [2])
Age
Item
patients must be greater than or equal to 18 years of age.
boolean
C0001779 (UMLS CUI [1])
contraception
Item
patients and/or their partners must be willing to practice a non-hormonal method of contraception during therapy and for 6 months following therapy.
boolean
C0700589 (UMLS CUI [1])
comorbidities, compliance
Item
patients who are poor medical or psychiatric risks because of nonmalignant systemic disease which would preclude them from being subjected to any treatments in this protocol are excluded.
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
heart function, heart diseases
Item
patients must have a normal ejection fraction by muga scan and have no angina. patients should not currently require therapy for cardiac arrhythmias, congestive heart failure, or coronary artery disease.
boolean
C0018799 (UMLS CUI [1])
C0232164 (UMLS CUI [2])
CNS disease
Item
no patients with a history of symptomatic cns disease.
boolean
C0007682 (UMLS CUI [1])
Allergy to protocol agent
Item
no patients with allergy to any study medication.
boolean
C0020517 (UMLS CUI [1,1])
C1521826 (UMLS CUI [1,2])
pregnant or lactating
Item
no pregnant or lactating women.
boolean
C0032961 (UMLS CUI [1])
C2828358 (UMLS CUI [2])
bleeding disorders, anticoagulation
Item
patients with bleeding disorders are ineligible for study entry as are patients requiring chronic anticoagulation.
boolean
C0005779 (UMLS CUI [1])
C0003280 (UMLS CUI [2])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial